Beecken Petty O’Keefe & Company Completes Sale of Southern Anesthesia + Surgical

Chicago, IL., May 2, 2017

–Beecken Petty O’Keefe & Company, a leading Chicago-based

private equity management firm focused exclusively on the healthcare industry, announced
today the completion of its sale of Southern Anesthesia + Surgical (SAS), a leading U.S.
distributor of anesthesia and surgical supplies to oral surgeons, dental anesthesiologists, and
periodontists to Henry Schein, Inc. (NASDAQ:HSIC). The transaction was announced on
February 20, 2017. Financial terms of the transaction were not disclosed.
SAS offers controlled and non-controlled pharmaceuticals supplies to almost 12,000 customers
nationwide. The company services that customer base through its headquarters located in
Columbia, SC, as well as through facilities in Reno, NV and Tulsa, OK.
Beecken Petty O’Keefe & Company (“BPOC”) is a leading Chicago-based private equity
management firm founded in 1996 to invest in middle-market buy-out transactions,
recapitalizations, and growth platforms exclusively in the healthcare industry, one of the largest
and fastest growing economic sectors.
As one of the longest-tenured, pure play healthcare private equity firms in the United States,
BPOC has structured, managed and realized investments on behalf of institutional and
individual investors for nearly two decades.
Since its formation, BPOC has raised four funds with total capital commitments of over $1.375
billion and has completed investments in 42 companies. BPOC’s objective is to identify and
invest in healthcare companies with superior management teams to produce consistent and
significant equity returns for our investors and investment partners.